During the last decade different biochemical markers of sepsis – C reactive protein (CRP), procalcitonin (PCT), inflammatory cytokines and acute phase reactants have been successfully studied and used in clinical practice in determining the onset of sepsis and quantifying the response to therapy. The gene discussed is CRP; the disease is Sepsis.